First Trust Advisors LP lifted its position in shares of Relx Plc (NYSE:RELX – Free Report) by 799.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,129 shares of the technology company’s stock after purchasing an additional 38,335 shares during the quarter. First Trust Advisors LP’s holdings in Relx were worth $1,959,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the company. CENTRAL TRUST Co increased its holdings in Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after buying an additional 529 shares during the period. Versant Capital Management Inc bought a new stake in Relx in the fourth quarter valued at about $31,000. Sierra Ocean LLC bought a new stake in Relx in the fourth quarter valued at about $43,000. Brown Brothers Harriman & Co. raised its position in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company’s stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Finally, Private Trust Co. NA lifted its stake in Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock worth $56,000 after purchasing an additional 199 shares during the period. 15.02% of the stock is currently owned by institutional investors.
Relx Stock Performance
Relx stock opened at $55.05 on Tuesday. Relx Plc has a 12-month low of $41.94 and a 12-month high of $55.21. The stock has a 50-day simple moving average of $50.10 and a 200 day simple moving average of $48.51. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The stock has a market capitalization of $101.88 billion, a price-to-earnings ratio of 29.59, a P/E/G ratio of 2.73 and a beta of 0.86.
Relx Increases Dividend
Analyst Ratings Changes
A number of equities analysts have recently issued reports on RELX shares. The Goldman Sachs Group began coverage on Relx in a report on Wednesday, March 26th. They issued a “buy” rating for the company. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. StockNews.com downgraded shares of Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. Finally, Redburn Atlantic initiated coverage on shares of Relx in a research report on Wednesday, January 8th. They issued a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy”.
Get Our Latest Stock Report on RELX
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- How to Use the MarketBeat Dividend Calculator
- Monster Beverage Stock: Short Report Risks vs Upside Potential
- How to Read Stock Charts for Beginners
- Onsemi Stock Confirms Bottom, But What’s the Upside?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Tech Leaders Announce Buybacks Totaling $85 Billion
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.